| Literature DB >> 34373773 |
Xiaoming Zhao1, Wei Gong1, Xing Li1, Weibing Yang2, Dengfeng Yang2, Zhiguo Liu2.
Abstract
Objective: To explore the application value of ultrasound image based on back propagation (BP) neural network algorithm in knee osteoarthritis (KOA) and evaluate the application effect and value of ultrasound image technology based on the BP neural network in the diagnosis of knee osteoarthritis cartilage lesions, 98 patients who were admitted to our hospital were diagnosed with KOA and had undergone arthroscopic soft tissue examinations were randomly selected. According to whether image processing was performed, the ultrasound images of all patients were divided into two groups. The control group was image before processing, and the experimental group was image after processing optimization. The consistency of the inspection results of the ultrasound images before and after the processing with the arthroscopy results was compared. The results showed that the staging accuracy of the control group was 68.3% and that of the experimental group was 76.9%. The accuracy of staging cartilage degeneration of the experimental group was higher than that of the control group, and the difference was not remarkable (P > 0.05). The kappa coefficient of the experimental group was 0.61, and that of the control group was 0.40. The kappa coefficient of the experimental group was higher than that of the control group, and the difference was significant (P < 0.05).Entities:
Year: 2021 PMID: 34373773 PMCID: PMC8349257 DOI: 10.1155/2021/2584291
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 2.682
Figure 1KOA diagnostic criteria customized by the American Association of Rheumatology (ACR) in 2001.
Figure 2Process of high-frequency ultrasound examination.
Staging criteria of knee cartilage degeneration under arthroscopy.
| Stage | The state of cartilage lesions |
|---|---|
| Stage I | The cartilage tissue loses its luster and becomes hard in texture |
| Stage II | The surface of the cartilage is not smooth, with blisters or velvet-like changes, and the invasion range of the damage is less than 1/2 of the depth of the cartilage. |
| Stage III | The cartilage lesions are severe, with local thinning or even fibrosis, and the invasion range of the injury is more than 1/2 of the cartilage depth. |
| Stage IV | The cartilage has ulcerated lesions, complete defects, and exposed subchondral bone tissue. |
Staging criteria of knee cartilage degeneration under ultrasound detection.
| Stage | Cartilage status under ultrasound |
|---|---|
| No lesion | The surface shows high echo and the lines are smooth, clear, and continuous. The boundary between cartilage and its inferior bone is normal, and the lower vocal cords are evenly distributed and of normal thickness. |
| Stage I | The change degree is small or the surface is rough, the thickness is close to normal, the degenerated deep layer shows high echo, the sound line is continuous, the smooth slightly less, and the internal echo distribution is basically uniform |
| Stage II | The surface shows hyperecho and coarse sound line with localized uplift. The deep sound line of the lesion site shows continuous hyperecho with increased echo and uneven distribution. |
| Stage III | Thin, with obvious defect, but no invasion of subchondral tissue, uneven distribution of low vocal cords, cartilage interruption defect, degenerative deep high echo, irregular voice line increase, showing extremely coarse, local defect |
| Stage IV | The subchondral bone is exposed, the deep high echo line is discontinuous, the central low echo cord is thinned, the cartilage defect area is enlarged, and the subchondral bone is invaded, obviously thinned, and the whole layer is thinned. |
Figure 3Comparison of ultrasound images (a) before and (b) after BP neural network algorithm processing. The red arrow refers to the articular cavity.
Staging results of different articular surface cartilage lesions under arthroscopic examination (place).
| Staging | Inspection area | |||||
|---|---|---|---|---|---|---|
| Stage I | Stage II | Stage III | Stage IV | Total | ||
| Central groove of pulley | The central sulcus | 10 | 18 | 11 | 7 | 164 |
| The inside of the slope | 12 | 18 | 16 | 17 | ||
| The outside of the slope | 9 | 17 | 18 | 11 | ||
|
| ||||||
| The femoral | The medial condyle | 12 | 21 | 25 | 27 | 155 |
| The lateral condyle | 12 | 11 | 24 | 23 | ||
Figure 4The manifestations of different stages under arthroscopy. (a) Stage I. (b) Stage II. (c) Stage III. (d) Stage IV.
Results of different articular surface cartilage lesion stages in the control group (place).
| Staging | Inspection area | |||||
|---|---|---|---|---|---|---|
| Stage I | Stage II | Stage III | Stage IV | Total | ||
| Central groove of pulley | The central sulcus | 7 | 11 | 10 | 11 | 164 |
| The inside of the slope | 6 | 20 | 17 | 26 | ||
| The outside of the slope | 5 | 17 | 20 | 14 | ||
|
| ||||||
| The femoral | The medial condyle | 15 | 22 | 25 | 5 | 120 |
| The lateral condyle | 7 | 29 | 11 | 8 | ||
Figure 5The ultrasound imaging manifestations of different stages in the control group. (a) Normal. (b) Stage I. (c) Stage II. (d) Stage III. (e) Stage IV.
Results of different articular surface cartilage lesion stages in the experimental group (place).
| Staging | Inspection area | |||||
|---|---|---|---|---|---|---|
| Stage I | Stage II | Stage III | Stage IV | Total | ||
| Central groove of pulley | The central sulcus | 8 | 16 | 11 | 9 | 169 |
| The inside of the slope | 7 | 20 | 18 | 25 | ||
| The outside of the slope | 7 | 15 | 20 | 13 | ||
|
| ||||||
| The femoral | The medial condyle | 13 | 20 | 20 | 22 | 138 |
| The lateral condyle | 9 | 16 | 18 | 20 | ||
Figure 6The ultrasound imaging manifestations of different stages in the experimental group. (a) Normal. (b) Stage I. (c) Stage II. (d) Stage III. (e) Stage IV.
Figure 7Comparison of the staging results of the two groups of ultrasound images with the results under arthroscopy. A: staging accuracy. B: kappa coefficient. : the kappa value of the two groups was statistically significant (P < 0.05).